Background: Pulmonary complications and infections frequently affect patients with head and neck squamous cell carcinoma (HNSCC). Common characteristics can predispose these patients to the development of severe respiratory illness, which may be particularly relevant during the 2019 coronavirus disease (COVID-19) pandemic.
Methods: A scoping review was performed to assess the impact of pulmonary comorbidities and adverse respiratory outcomes in HNSCC patients.
Results: Advanced age, history of tobacco and alcohol abuse, and cardiopulmonary comorbidities are significant risk factors for the development of adverse respiratory outcomes. Treatment toxicities from radiation or chemoradiation therapy significantly increase these risks.
Conclusion: Respiratory complications are a frequent cause of morbidity and mortality among HNSCC patients, and the COVID-19 pandemic may disproportionately affect this population. Interventions designed to decrease smoking and alcohol use, improve oral hygiene, and aggressively manage medical comorbidities are important to the long-term management and health of these patients.
Keywords: COVID-19; adverse respiratory outcomes; head and neck squamous cell carcinoma (HNSCC); pulmonary comorbidities; respiratory infections and complications.
© 2020 Wiley Periodicals, Inc.
Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.Curr Oncol. 2010 Jun;17(3):37-48. doi: 10.3747/co.v17i3.520. Curr Oncol. 2010. PMID: 20567625 Free PMC article.
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5:CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. PMID: 32406927
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.Oral Oncol. 2020 Jun;105:104684. doi: 10.1016/j.oraloncology.2020.104684. Epub 2020 Apr 6. Oral Oncol. 2020. PMID: 32330858 Free PMC article. Review.
Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.Head Neck. 2020 Jun;42(6):1147-1149. doi: 10.1002/hed.26216. Epub 2020 Apr 28. Head Neck. 2020. PMID: 32343444
Tobacco-related carcinogenesis in head and neck cancer.Cancer Metastasis Rev. 2017 Sep;36(3):411-423. doi: 10.1007/s10555-017-9689-6. Cancer Metastasis Rev. 2017. PMID: 28801840 Free PMC article. Review.
- Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337.
- Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020. https://doi.org/10.1016/j.annonc.2020.03.296.
- Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB. Causes of death in long-term survivors of head and neck cancer. Cancer. 2014;120(10):1507-1513.
- Ferrier MB, Spuesens EB, Le Cessie S, de Jong RJB. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg. 2005;131(1):27-32.
- Francis DO, Weymuller EA Jr, Parvathaneni U, Merati AL, Yueh B. Dysphagia, stricture, and pneumonia in head and neck cancer patients: does treatment modality matter? Ann Otol Rhinol Laryngol. 2010;119(6):391-397.